These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 26280952

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
    Chaléat-Valayer E, Parratte B, Colin C, Denis A, Oudin S, Bérard C, Bernard JC, Bourg V, Deleplanque B, Dulieu I, Evrard P, Filipetti P, Flurin V, Gallien P, Héron-Long B, Hodgkinson I, Husson I, Jaisson-Hot I, Maupas E, Meurin F, Monnier G, Pérennou D, Pialoux B, Quentin V, Moreau MS, Schneider M, Yelnik A, Marque P.
    Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
    [Abstract] [Full Text] [Related]

  • 4. Localization of the motor endplate zone in human skeletal muscles of the lower limb: anatomical guidelines for injection with botulinum toxin.
    Van Campenhout A, Molenaers G.
    Dev Med Child Neurol; 2011 Feb; 53(2):108-19. PubMed ID: 20964675
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
    Madsen ES, Sonne-Holm S, Wong C, Curtis D, Bencke J.
    Ugeskr Laeger; 2015 Jan 12; 177(3):V07140409. PubMed ID: 25613095
    [Abstract] [Full Text] [Related]

  • 7. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA, Elliott C, Valentine J, Gubbay A, Shipman P, Reid S.
    Disabil Rehabil; 2013 Apr 12; 35(7):596-605. PubMed ID: 22928803
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
    El O, Peker O, Kosay C, Iyilikci L, Bozan O, Berk H.
    J Child Neurol; 2006 Dec 12; 21(12):1009-12. PubMed ID: 17156689
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effectiveness of Multilevel Botulinum Toxin A Injection with Integrated Treatment Program on Spasticity Reduction in Non-Ambulatory Young Children with Cerebral Palsy.
    Aydil S, Akpinar FM, Akpinar E, Beng K, Yagmurlu MF.
    Med Princ Pract; 2019 Dec 12; 28(4):309-314. PubMed ID: 30840957
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Instrumented assessment of the effect of Botulinum Toxin-A in the medial hamstrings in children with cerebral palsy.
    Bar-On L, Aertbeliën E, Molenaers G, Van Campenhout A, Vandendoorent B, Nieuwenhuys A, Jaspers E, Hunaerts C, Desloovere K.
    Gait Posture; 2014 Jan 12; 39(1):17-22. PubMed ID: 23791154
    [Abstract] [Full Text] [Related]

  • 15. Application of botulinum toxin in treatment of spasticity and functional improvements for children suffering from cerebral palsy.
    Meholjic A, Madjar D.
    Med Arh; 2010 Jan 12; 64(6):359-61. PubMed ID: 21218755
    [Abstract] [Full Text] [Related]

  • 16. Clinical effects of botulinum toxin A and phenol block on gait in children with cerebral palsy.
    Wong AM, Chen CL, Chen CP, Chou SW, Chung CY, Chen MJ.
    Am J Phys Med Rehabil; 2004 Apr 12; 83(4):284-91. PubMed ID: 15024330
    [Abstract] [Full Text] [Related]

  • 17. Potentiation of botulinum toxin type A with oral anti-spasticity medications in the management of focal spasticity.
    Dai A.
    J Rehabil Med; 2007 Mar 12; 39(2):189; author reply 189. PubMed ID: 17351705
    [No Abstract] [Full Text] [Related]

  • 18. Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy?
    Bar-On L, Van Campenhout A, Desloovere K, Aertbeliën E, Huenaerts C, Vandendoorent B, Nieuwenhuys A, Molenaers G.
    Arch Phys Med Rehabil; 2014 Mar 12; 95(3):515-23. PubMed ID: 23994052
    [Abstract] [Full Text] [Related]

  • 19. [An electromyographic study on the development of optimal tactics of botulinum toxin type A injections in children with spastic forms of cerebral palsy].
    Kurenkov AL, Kuzenkova LM, Burgasova BI, Petrova SA, Klochkova OA, Nikitin SS, Artemenko AR, Mamed'iarov AM.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013 Mar 12; 113(5 Pt 2):53-60. PubMed ID: 23739515
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.